Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010
Sponsor: HaEmek Medical Center, Israel
This observational or N/A phase trial investigates Premature and Thrombosis and is currently ongoing. HaEmek Medical Center, Israel leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Nov 2021 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Dec 2019 — Jan 2021 [monthly]
Recruiting
Status: Unknown Status → Recruiting
▶ Show 4 earlier versions
-
Sep 2019 — Dec 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Sep 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- HaEmek Medical Center, Israel
For direct contact, visit the study record on ClinicalTrials.gov .